Teleflex announces large-scale analysis of real-world healthcare claims data for enlarged prostate procedures at the American Urological Association 2021 Annual Meeting

Teleflex Incorporated announced that new real-world healthcare claims data reveal that the risk of return procedures is lowest after treatment with the UroLift System among the analyzed benign prostatic hyperplasia (BPH) treatment options. The data also show that the risk of surgical retreatment is similar between UroLift PUL, TURP and GreenLight PVP while highest following Rezum Water Vapor Therapy. The […]